QR code

Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial

Abstract Background Cryptosporidium infection and diarrhea (cryptosporidiosis) is a life-threatening infection in persons with HIV and also in children of 6–18 months of age in the developing world. To date, only nitazoxanide is licensed for treatment of cryptosporidiosis, and only in persons after...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Patrick Nachipo, David Hermann, Gerald Quinnan, Melita A. Gordon, Wesley C. Van Voorhis, Pui-Ying Iroh Tam
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMC 2018-08-01
Reeks:Trials
Onderwerpen:
Cryptosporidium
Diarrhea
HIV
Clofazimine
Lamprene
Immunosuppression
Online toegang:http://link.springer.com/article/10.1186/s13063-018-2846-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items